Literature DB >> 10629566

Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.

A Ismail1, A M El Hassan, K Kemp, S Gasim, A E Kadaru, T Moller, A Kharazmi, T G Theander.   

Abstract

In Sudan, post kala-azar dermal leishmaniasis (PKDL) caused by Leishmania donovani develops in half of the patients treated for visceral leishmaniasis (kala-azar). In most patients lesions heal spontaneously, but in others symptoms are severe and persist for years. This study examined the immunological response in lesions of PKDL patients by immunohistochemistry and compared the findings with results obtained using peripheral blood mononuclear cells (PBMCs). In all lesions, parasites or parasite antigen were present and provoked the formation of an inflammatory infiltrate consisting of a mixture of macrophages, lymphocytes, and plasma cells. In patients who had high interferon-gamma (IFNgamma) responses to Leishmania antigen in vitro, compact epithelioid granulomas were formed. The inflammatory cells were mainly CD3(+) and interleukin-10 (IL10) was the most prominent cytokine in the lesions. However, IFNgamma was found in all and IL4 in most lesions, in varying amounts. PBMCs from all patients responded to Leishmania antigen by IFNgamma production or proliferation. The results indicate that PKDL develops as a result of an influx of immunocompetent cells into skin, which harbours parasites. The inflammatory response to the parasites is complex. It involves several cell types and cytokines, of which some are antagonistic. It is conceivable that the balance between these cytokines determines the outcome of the disease. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629566     DOI: 10.1002/(SICI)1096-9896(199912)189:4<615::AID-PATH466>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan.

Authors:  M A Salih; M E Ibrahim; J M Blackwell; E N Miller; E A G Khalil; A M ElHassan; A M Musa; H S Mohamed
Journal:  Genes Immun       Date:  2006-11-30       Impact factor: 2.676

3.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

4.  Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Authors:  H Kaushal; R Bras-Gonçalves; K Avishek; D Kumar Deep; E Petitdidier; J-L Lemesre; G Papierok; S Kumar; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

5.  Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Authors:  Shamim Islam; Eben Kenah; Mohammed Ashraful Alam Bhuiyan; Kazi Mizanur Rahman; Brook Goodhew; Chowdhury Mohammad Ghalib; M M Zahid; Masayo Ozaki; M W Rahman; Rashidul Haque; Stephen P Luby; James H Maguire; Diana Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

Review 6.  Present status of antileishmanial vaccines.

Authors:  Monidipa Ghosh; Santu Bandyopadhyay
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.

Authors:  Charles F Anderson; Jason S Stumhofer; Christopher A Hunter; David Sacks
Journal:  J Immunol       Date:  2009-09-11       Impact factor: 5.422

8.  T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

Authors:  Tobias Schwarz; Katharina A Remer; Wiebke Nahrendorf; Anita Masic; Lisa Siewe; Werner Müller; Axel Roers; Heidrun Moll
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

9.  Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population.

Authors:  S Farouk; M A Salih; A M Musa; J M Blackwell; E N Miller; E A Khalil; A M Elhassan; M E Ibrahim; H S Mohamed
Journal:  Public Health Genomics       Date:  2009-12-29       Impact factor: 2.000

10.  Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis.

Authors:  Ahmed Mohamed El Hassan; Eltahir Awad Gasim Khalil; Waleed Mohamed Elamin; Lamyaa Ahmed Mohamed El Hassan; Mogtaba Elsaman Ahmed; Ahmed Mudawi Musa
Journal:  Case Rep Med       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.